A phase II study of cisplatin plus S-1 in patients with carcinomas of unknown primary site.
T. Kurata
No relevant relationships to disclose
A. Tsuya
No relevant relationships to disclose
A. Tamiya
No relevant relationships to disclose
I. Okamoto
Honoraria - Taiho Pharmaceutical
S. Ueda
No relevant relationships to disclose
N. Sugimoto
No relevant relationships to disclose
K. Matsumoto
No relevant relationships to disclose
I. Goto
No relevant relationships to disclose
M. Fukuoka
No relevant relationships to disclose
K. Nakagawa
Honoraria - Taiho Pharmaceutical